Loading clinical trials...
Loading clinical trials...
This study aims at evaluating the role of Atorvastatin in prevention of Anthracycline induced cardiotoxicity
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Ain Shams University
NCT06427226 · Doxorubicin Induced Cardiomyopathy, Breast Cancer
NCT07370506 · Breast Cancer, Doxorubicin Induced Cardiomyopathy
NCT05731375 · Doxorubicin Induced Cardiomyopathy, Chemotherapeutic Toxicity, and more
NCT03000036 · Breast Cancer Female, Doxorubicin Induced Cardiomyopathy
Ain Shams University hospitals
Cairo
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions